Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celldex Therapeutics Inc (NASDAQ:CLDX)

3.78
Delayed Data
As of 3:59pm ET
 -0.12 / -3.08%
Today’s Change
2.96
Today|||52-Week Range
18.62
-75.89%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$392.1M

Company Description

Celldex Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes therapeutic antibodies, antibody drug conjugates, vaccines, and immune system modulators. Its drug candidates include Glembatumumab vedotin, Varlilumab, CDX-1401, CDX-301, and Rintega. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.

Contact Information

Celldex Therapeutics, Inc.
Perryville III Building
Hampton New Jersey 08827
P:(908) 200-7500
Investor Relations:

Employees

Shareholders

Mutual fund holders54.33%
Other institutional27.07%
Individual stakeholders0.95%

Top Executives

Anthony S. MarucciPresident, Chief Executive Officer & Director
Avery W. CatlinCFO, Secretary, Treasurer & Senior Vice President
Tibor KelerChief Scientific Officer & Executive VP
Thomas Andrew DavisChief Medical Officer & Executive Vice President
Elizabeth CrowleyChief Product Development Officer & SVP